Can AI predict the next pandemic? A new study says yes

Researchers explore how artificial intelligence is transforming infectious disease modeling

GH Research Reports Second Quarter 2023 Financial Results and Provides Business Updates | Psychedelic Invest

GH Research PLC (Nasdaq: GHRS), a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders, today reported financial results for the

August 23, 2023

Royalty Pharma inks MS deal with ImmuNext; X4 sells its priority review voucher

Plus, news about Pacira Biosciences, Cassava Sciences, Merck, Monopar Therapeutics, Eli Lilly and Optinose: Royalty Pharma signs MS deal: The company will pay about $525

May 10, 2024

Intarcia’s diabetes drug-device combo voted down again by FDA panel

A Food and Drug Administration advisory committee voted unanimously on Thursday afternoon to reject an appeal for Intarcia Therapeutics’ Type 2 diabetes drug-device combination treatment,

September 25, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.